NARA Discovery
Article Details
← Back to Search Results
Journal Article

Leaf extracts of eight selected southern African medicinal plants modulate pro-inflammatory cytokine secretion in LPS-stimulated RAW 264.7 macrophages

Gugulethu P. Khumalo; Wendy Loa-Kum-Cheung; Ben-Erik Van Wyk; Yunjiang Feng; Ian E. Cock
Inflammopharmacology · Vol. 32, Issue 2 · pp. 1607-1620 · 2024

Abstract

This study investigates the anti-inflammatory properties of extracts prepared from the leaves of eight southern African medicinal plants used traditionally to treat inflammation and pain. The inhibitory effect of aqueous and ethanol extracts on the release of pro-inflammatory cytokines was determined in lipopolysaccharide (LPS) stimulated and unstimulated RAW 264.7 murine macrophage cells. The levels of interleukin (IL)-1β, IL-6, tumour necrosis factor-α (TNF-α), interferon-gamma (IFN-γ), monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein (MIP)-2 release were determined using cytokine multiplex-bead assays. The ethanol extracts of Melianthus comosus Vahl (commonly known as honey flower), Tetradenia riparia (Hochst.) Codd (misty plume bush) and Warburgia salutaris (G. Bertol.) Chiov. (pepper-bark tree), demonstrated the most significant inhibitory activity, with over 50-fold inhibition of IL-1β, IL-6 and TNF-α levels in LPS-stimulated RAW 264.7 macrophages. The aqueous extract of M. comosus also significantly inhibited the secretion of all the tested cytokines and chemokines. Phytochemical investigation of M. comosus ethanol leaf extract using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry (UHPLC-HRMS) led to the detection of crassolide, deoxylimonoic acid D-ring-lactone, 2-hydroxynonanoic acid and 5-noniloxytryptamine. To the best of our knowledge, the cytokine inhibition properties of most of the medicinal plants screened in this study are reported for the first time. Our results support the use of southern African medicinal plants as anti-inflammatory remedies and provide an insight into the immunomodulatory mechanisms of action.

Bibliographic Information

JournalInflammopharmacology
PublisherSpringer
Publication Date2024-04-01
Publication Year2024
Volume32
Issue2
Pages1607-1620
Document TypeJournal Article
Print ISSN0925-4692
eISSN1568-5608
DOI10.1007/s10787-023-01420-9

Access Information

NARA Access Coverage1991-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10787
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.